Li Xiaoqiao, Cheng Ming, Liu Min, Li Wenjing, Li Yuchuan, Cao Bingyan, Wei Liya, Ding Yuan, Meng Xi, Li Lele, Gong Chunxiu
Department of Endocrinology, Genetics, Metabolism Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China.
Pediatr Investig. 2025 Jul 2;9(3):293-299. doi: 10.1002/ped4.70013. eCollection 2025 Sep.
Cornelia de Lange syndrome (CdLS) is a rare genetic disorder characterized by a spectrum of developmental and physical anomalies. Understanding the clinical and genetic landscape of CdLS in pediatric patients is crucial for improving diagnosis and management.
To investigate the clinical and genetic characteristics of 19 pediatric patients with CdLS in China, with a focus on identifying the association between genetic variants and clinical severity.
We performed whole exome sequencing on 19 patients with CdLS and compared their clinical characteristics based on the presence of null variants.
Among the 19 patients, 16 (84.2%) showed global developmental delays and 14 (73.7%) experienced prenatal growth retardation and short stature. Craniofacial anomalies-short noses and anteverted nares were observed in 94.7% (18/19) of patients. Small hands and/or feet were present in 16 patients, skin manifestations (hirsutism or mottled skin) in six, and hearing loss in four. Genetic testing identified 19 variants in (78.9%, 15/19), (10.5%, 2/19), and (10.5%, 2/19), including 13 novel variants. null variants correlated significantly with more severe growth impairments ( = 0.016) and microcephaly ( = 0.004). Although complete protein function loss often correlated with more severe clinical presentations, no significant difference in clinical scoring was observed ( = 0.600). Three patients treated with recombinant human growth hormone showed heterogeneous responses.
This study highlights the clinical heterogeneity of CdLS and suggests a potential link between specific genetic variants and disease severity. These findings warrant further research to optimize treatments and better understand the functional impact of these genetic variants.
科妮莉亚·德朗热综合征(CdLS)是一种罕见的遗传性疾病,其特征为一系列发育和身体异常。了解小儿患者CdLS的临床和基因情况对于改善诊断和管理至关重要。
研究中国19例小儿CdLS患者的临床和基因特征,重点是确定基因变异与临床严重程度之间的关联。
我们对19例CdLS患者进行了全外显子组测序,并根据无效变异的存在情况比较了他们的临床特征。
在19例患者中,16例(84.2%)表现为全面发育迟缓,14例(73.7%)经历了产前生长迟缓及身材矮小。94.7%(18/19)的患者存在颅面异常——短鼻和鼻孔前倾。16例患者有小手和/或小脚,6例有皮肤表现(多毛症或皮肤斑驳),4例有听力损失。基因检测在(78.9%,15/19)、(10.5%,2/19)和(10.5%,2/19)中鉴定出19种变异,包括13种新变异。无效变异与更严重的生长障碍(=0.016)和小头畸形(=0.004)显著相关。虽然完全的蛋白质功能丧失通常与更严重的临床表现相关,但在临床评分上未观察到显著差异(=0.600)。3例接受重组人生长激素治疗的患者表现出不同的反应。
本研究突出了CdLS的临床异质性,并提示特定基因变异与疾病严重程度之间可能存在联系。这些发现值得进一步研究,以优化治疗方法并更好地理解这些基因变异的功能影响。